Bensen Daniel, Chief Discovery Officer at Tyra Biosciences ($TYRA), sold about $4.8 million in company shares across 11 open market transactions over the past year. His most recent sale occurred on February 12, 2026. These sales rank him 1,995th among 11,678 insiders by total value sold, below the average of $8.6 million per seller and 6.4 transactions. Daniel made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Discovery Officer | S | Common Stock | 2128 | $31.50 | 152,853.0000 | 59,670,757 | 1.37% | 0.00% |
| Feb. 12, 2026 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Discovery Officer | S | Common Stock | 5872 | $33.37 | 146,981.0000 | 59,670,757 | 3.84% | 0.01% |
| Jan. 12, 2026 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Discovery Officer | S | Common Stock | 1017 | $29.08 | 154,981.0000 | 59,670,757 | 0.65% | 0.00% |
| Jan. 12, 2026 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Discovery Officer | S | Common Stock | 6983 | $28.44 | 155,998.0000 | 59,670,757 | 4.28% | 0.01% |
| Dec. 12, 2025 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Discovery Officer | S | Common Stock | 8000 | $22.64 | 162,981.0000 | 59,670,757 | 4.68% | 0.01% |
| Nov. 19, 2025 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 49956 | $16.32 | 170,981.0000 | 59,670,757 | 22.61% | 0.08% |
| Nov. 18, 2025 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 75633 | $16.07 | 220,937.0000 | 59,670,757 | 25.50% | 0.13% |
| Nov. 14, 2025 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 110228 | $16.02 | 316,642.0000 | 59,670,757 | 25.82% | 0.18% |
| Nov. 17, 2025 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 1500 | $17.07 | 296,570.0000 | 59,670,757 | 0.50% | 0.00% |
| Nov. 17, 2025 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 18572 | $16.11 | 298,070.0000 | 59,670,757 | 5.87% | 0.03% |
| Nov. 13, 2025 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 1111 | $16.00 | 426,870.0000 | 59,670,757 | 0.26% | 0.00% |
| Aug. 7, 2025 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | A | Stock Option (Right to Buy) | 170000 | $0.00 | 170,000.0000 | 57,217,746 | 9999.99% | 0.30% |
| Aug. 14, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 42,704,876 | 9999.99% | 0.27% |
| June 7, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 200 | $20.00 | 431,483.0000 | 42,704,876 | 0.05% | 0.00% |
| June 10, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 3502 | $20.00 | 427,981.0000 | 42,704,876 | 0.81% | 0.01% |
| March 11, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 200 | $20.00 | 431,683.0000 | 42,704,876 | 0.05% | 0.00% |
| March 6, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 1733 | $20.09 | 431,951.0000 | 42,704,876 | 0.40% | 0.00% |
| March 7, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 68 | $20.00 | 431,883.0000 | 42,704,876 | 0.02% | 0.00% |
| March 5, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 1189 | $20.02 | 433,684.0000 | 42,704,876 | 0.27% | 0.00% |
| March 1, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 2900 | $20.04 | 439,936.0000 | 42,704,876 | 0.65% | 0.01% |
| March 4, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 5063 | $20.08 | 434,873.0000 | 42,704,876 | 1.15% | 0.01% |
| Feb. 27, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 745 | $20.00 | 450,735.0000 | 42,704,876 | 0.17% | 0.00% |
| Feb. 28, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 5849 | $20.13 | 444,886.0000 | 42,704,876 | 1.30% | 0.01% |
| Feb. 29, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 2050 | $20.00 | 442,836.0000 | 42,704,876 | 0.46% | 0.00% |
| Feb. 12, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 1501 | $20.00 | 451,480.0000 | 42,704,876 | 0.33% | 0.00% |
| Feb. 7, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 9587 | $18.09 | 452,981.0000 | 42,704,876 | 2.07% | 0.02% |
| Feb. 2, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 2300 | $17.04 | 477,981.0000 | 42,704,876 | 0.48% | 0.01% |
| Feb. 2, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | M | Stock Option (Right to Buy) | 25393 | $0.00 | 108,110.0000 | 42,704,876 | 19.02% | 0.06% |
| Feb. 2, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | M | Common Stock | 25393 | $0.61 | 553,374.0000 | 42,704,876 | 4.81% | 0.06% |
| Feb. 2, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 73093 | $16.31 | 480,281.0000 | 42,704,876 | 13.21% | 0.17% |
| Feb. 6, 2024 | Tyra Biosciences, Inc. | $TYRA | Bensen Daniel | Chief Operating Officer | S | Common Stock | 15413 | $18.09 | 462,568.0000 | 42,704,876 | 3.22% | 0.04% |